Jiangsu Lanfeng Bio-chemical Co Ltd
SZSE:002513
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (26.3), the stock would be worth ¥-17.07 (384% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -9.3 | ¥6.02 |
0%
|
| Industry Average | 26.3 | ¥-17.07 |
-384%
|
| Country Average | 20.8 | ¥-13.52 |
-325%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
J
|
Jiangsu Lanfeng Bio-chemical Co Ltd
SZSE:002513
|
2.1B CNY | -9.3 | -14.8 | |
| US |
|
Corteva Inc
NYSE:CTVA
|
53.6B USD | 14.7 | 48.7 | |
| CA |
|
Nutrien Ltd
TSX:NTR
|
47.7B CAD | 11 | 14.9 | |
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
188.9B CNY | 16.5 | 22.7 | |
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
25.4B USD | 22.6 | 43.2 | |
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
137.1B CNY | 70.4 | 29.3 | |
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
18.6B USD | 7.2 | 12.8 | |
| NO |
|
Yara International ASA
OSE:YAR
|
136.8B NOK | 8.7 | 10.5 | |
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR | 7.7 | 12.4 | |
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
912.2B RUB | 9 | 7.9 | |
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
77.1B CNY | 20 | 23.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.5 |
| Median | 20.8 |
| 70th Percentile | 39.2 |
| Max | 266 666.7 |
Other Multiples
Jiangsu Lanfeng Bio-chemical Co Ltd
Glance View
Jiangsu Lanfeng Biochemical Co., Ltd. engages in the manufacture and sale of agrochemical and pharmaceutical products. The company is headquartered in Xuzhou, Jiangsu and currently employs 1,404 full-time employees. The company went IPO on 2010-12-03. is a China-based company mainly engaged in the manufacture of fungicides, herbicides, insecticides and the fine chemical intermediate products. The Company’s products consist of fungicides, such as carbendazim suspending agents, carbendazim wettable powders, thiophanate-methyl wettable powders and others; herbicides, such as sugarcane herbicides; insecticides, such as chloronicotinyl insecticides, pyrethriods pesticides, acaricide and others, and fine chemical intermediate products, such as ethyl chloroformate and methylclhlorofonmate. The firm also provides raw materials, such as thiophanate-methyl raw materials, carbendazim raw materials and benomyl, as well as processing products, sulfuric acids and other products. The firm is also engaged in the research, development, production and distribution of pharmaceuticals. The firm distributes its products within domestic market and to overseas markets.
